Status:

UNKNOWN

Tear Concentrations and Pharmacokinetics of Azithromycin Eye Drops in Healthy Volunteers

Lead Sponsor:

Beijing Tongren Hospital

Collaborating Sponsors:

Grand Pharmaceutical (China) Co., Ltd.

Conditions:

Pharmacokinetics

Eligibility:

All Genders

18-45 years

Phase:

PHASE1

Brief Summary

To evaluate azithromycin tear concentrations after one drop of azithromycin eyedrops (2.5ml/25mg) in healthy volunteers.

Detailed Description

In this randomized, open, single-center study, 42 healthy volunteers will receive one drop of azithromycin into each eye. Azithromycin tear concentrations will be measured by LC-MS/MS at seven time po...

Eligibility Criteria

Inclusion

  • 18 to 45 years old, male or female;
  • BMI in the range of 19 to 24;
  • eyes corrected visual acuity should be ≥ 1.0, intraocular pressure, slit lamp and fundus examination were normal, tear secretion function is normal;
  • Good compliance and voluntarily signed consent.

Exclusion

  • Have eye disease or systemic disease;
  • physical examination, laboratory tests, ECG and chest X-ray examination abnormalities and has clinical significance;
  • HBsAg, anti-HCV, anti-HIV and TPPA positive;
  • those who used eye drops two weeks before the test and who used any dosage form of azithromycin;
  • known to azithromycin or macrolide-related varieties of allergies or serious adverse reactions;
  • need to wear contact lenses during the test;
  • history of internal surgery or laser surgery history;
  • participated in other drug clinical trials in the past three months;
  • pregnant women and lactating women, or in the growth period without taking effective contraceptive measures, menstrual period women;
  • mental illness or alcohol, history of drug abuse or inability to collaborate;
  • Any other circumstances that the investigators consider are unfit to participate in this study.

Key Trial Info

Start Date :

August 2 2017

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2017

Estimated Enrollment :

42 Patients enrolled

Trial Details

Trial ID

NCT03252067

Start Date

August 2 2017

End Date

December 31 2017

Last Update

August 17 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Beijing Tongren Hospital

Beijing, Beijing Municipality, China, 100730